These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32338110)

  • 21. Attention-deficit-hyperactivity disorder with and without oppositional defiant disorder in 3- to 7-year-old children.
    Kadesjö C; Hägglöf B; Kadesjö B; Gillberg C
    Dev Med Child Neurol; 2003 Oct; 45(10):693-9. PubMed ID: 14515941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caregivers' distress: youth with attention-deficit/hyperactivity disorder and comorbid disorders assessed via telemental health.
    Rockhill C; Violette H; Vander Stoep A; Grover S; Myers K
    J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):379-85. PubMed ID: 23952184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression.
    Gadow KD; Arnold LE; Molina BS; Findling RL; Bukstein OG; Brown NV; McNamara NK; Rundberg-Rivera EV; Li X; Kipp HL; Schneider J; Farmer CA; Baker JL; Sprafkin J; Rice RR; Bangalore SS; Butter EM; Buchan-Page KA; Hurt EA; Austin AB; Grondhuis SN; Aman MG
    J Am Acad Child Adolesc Psychiatry; 2014 Sep; 53(9):948-959.e1. PubMed ID: 25151418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine.
    Pringsheim T; Hirsch L; Gardner D; Gorman DA
    Can J Psychiatry; 2015 Feb; 60(2):42-51. PubMed ID: 25886655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of incontinence, attention deficit/hyperactivity disorder and oppositional defiant disorder in preschool children.
    Niemczyk J; Equit M; Braun-Bither K; Klein AM; von Gontard A
    Eur Child Adolesc Psychiatry; 2015 Jul; 24(7):837-43. PubMed ID: 25331539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High pretreatment cognitive impulsivity predicts response of oppositional symptoms to methylphenidate in patients with attention-deficit hyperactivity disorder/oppositional defiant disorder.
    Golubchik P; Shalev L; Tsamir D; Manor I; Weizman A
    Int Clin Psychopharmacol; 2019 May; 34(3):138-142. PubMed ID: 30640748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of web-assisted self-help for parents of children with ADHD (WASH) - a three-arm randomized trial under field/routine care conditions in Germany.
    Döpfner M; Wähnke L; Klemp MT; Mühlenmeister J; Schürmann S; Hellmich M; Plück J
    BMC Psychiatry; 2020 Feb; 20(1):76. PubMed ID: 32085706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Family functioning and psychosocial characteristics in children with attention deficit hyperactivity disorder with comorbid oppositional defiant disorder or conduct disorder].
    Kiliç BG; Sener S
    Turk Psikiyatri Derg; 2005; 16(1):21-8. PubMed ID: 15793695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of Parental ADHD in Sustaining the Effects of a Family-School Intervention for ADHD.
    Dawson AE; Wymbs BT; Marshall SA; Mautone JA; Power TJ
    J Clin Child Adolesc Psychol; 2016; 45(3):305-19. PubMed ID: 25496523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Possible Effect of Methylphenidate Treatment on Empathy in Children Diagnosed with Attention-Deficit/Hyperactivity Disorder, Both With and Without Comorbid Oppositional Defiant Disorder.
    Golubchik P; Weizman A
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):429-432. PubMed ID: 28398816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do parental ADHD symptoms reduce the efficacy of parent training for preschool ADHD? A secondary analysis of a randomized controlled trial.
    Forehand R; Parent J; Peisch VD; Sonuga-Barke E; Long N; Breslend NL; Abikoff HB
    Behav Res Ther; 2017 Oct; 97():163-169. PubMed ID: 28800444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors influencing elementary school teachers' ratings of ADHD and ODD behaviors.
    Stevens J; Quittner AL; Abikoff H
    J Clin Child Psychol; 1998 Dec; 27(4):406-14. PubMed ID: 9866077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a mindfulness-based intervention (MYmind) for children with ADHD and their parents: protocol for a randomised controlled trial.
    Chan SKC; Zhang D; Bögels SM; Chan CS; Lai KYC; Lo HHM; Yip BHK; Lau ENS; Gao TT; Wong SYS
    BMJ Open; 2018 Nov; 8(11):e022514. PubMed ID: 30420347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
    Spencer TJ; Abikoff HB; Connor DF; Biederman J; Pliszka SR; Boellner S; Read SC; Pratt R
    Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parent training for preschool ADHD: a randomized controlled trial of specialized and generic programs.
    Abikoff HB; Thompson M; Laver-Bradbury C; Long N; Forehand RL; Miller Brotman L; Klein RG; Reiss P; Huo L; Sonuga-Barke E
    J Child Psychol Psychiatry; 2015 Jun; 56(6):618-31. PubMed ID: 25318650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder.
    Newcorn JH; Spencer TJ; Biederman J; Milton DR; Michelson D
    J Am Acad Child Adolesc Psychiatry; 2005 Mar; 44(3):240-8. PubMed ID: 15725968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Callous-unemotional traits, proactive aggression, and treatment outcomes of aggressive children with attention-deficit/hyperactivity disorder.
    Blader JC; Pliszka SR; Kafantaris V; Foley CA; Crowell JA; Carlson GA; Sauder CL; Margulies DM; Sinha C; Sverd J; Matthews TL; Bailey BY; Daviss WB
    J Am Acad Child Adolesc Psychiatry; 2013 Dec; 52(12):1281-93. PubMed ID: 24290461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overlap of ADHD and oppositional defiant disorder DSM-IV derived criteria.
    Ghanizadeh A
    Arch Iran Med; 2011 May; 14(3):179-82. PubMed ID: 21529106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of methylphenidate treatment on psychopathic behavior of patients having attention-deficit hyperactivity disorder with and without oppositional defiant disorder.
    Golubchik P; Levy T; Weizman A
    Int Clin Psychopharmacol; 2018 Nov; 33(6):330-333. PubMed ID: 29958238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.